Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer.

Authors:
Harding MJ; Cantwell BM; Milstead RA; Harris AL; Kaye SB.

Journal:
Br J Cancer

Publication Year: 1988

PMCID:
PMC2246458

PMID:
3408648

View on PubMed View on PMC
Journal Information

Journal Title: Br J Cancer

Detailed journal information not available.

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025